Skip to main content
Log in

Endometriumkarzinom – operative Strategie und Adjuvanz

Ein möglicher Paradigmenwechsel

Endometrial cancer – operative strategy and adjuvant treatment

A possible paradigm shift

  • Gynäkologie aktuell
  • Published:
Der Gynäkologe Aims and scope

Zusammenfassung

In der Behandlung des Endometriumkarzinoms kommt der operativen Therapie unstrittig die zentrale Bedeutung zu. Die Hysterektomie mit beidseitiger Adnexektomie ist als Standard akzeptiert, zur Notwendigkeit einer höheren Radikalität sowohl in Bezug auf die Hysterektomie als auch die Indikationsstellung für eine pelvine und paraaortale Lymphonodektomie bei erhöhtem Rezidiv- und Metastasierungsrisiko dagegen, besteht weiterhin kein allgemeiner Konsens. Auf dem Boden einer sorgfältigen Analyse vorhandener Daten und neuer Erkenntnisse zum Ausbreitungsverhalten maligner Tumoren nehmen die Autoren eine subjektive Standortbestimmung vor und formulieren mögliche Die klassischen Behandlungsverfahren und deren Kombination werden in der internationalen NESTEC(Network Study in Endometrial Cancer)-Studie untersucht. Inwieweit sich das neue operative Konzept der radikalen Kompartment-basierten Operation (PMMR und therapeutische LNE) nach Höckel für eine Senkung lokoregionärer Rezidive auch des Endometriumkarzinoms eignet, muss ebenfalls prospektiv untersucht werden: Möglicherweise könnte die Radiatio aus der Primärtherapie vollständig herausgenommen werden und stünde so als lokoregionär hocheffektive Methode für eine Salvagetherapie beim Rezidiv zur Verfügung.

Abstract

The operative therapy indisputably plays the central role in the treatment of endometrial cancer. Hysterectomy with bilateral adnexectomy seems to be the accepted standard; however, this is contrasted by the necessity for greater radicality with respect to hysterectomy as well as indications for pelvic and para-aortic lymphadenectomy with an increased risk of recurrence and metastasis and is still a matter of intensive debate. This article presents a thorough assessment based on available data and a subjective estimation of the consequences for future therapeutic strategies. Different treatment strategies are currently investigated in the international network study in endometrial cancer (NESTEC); additional prospective trials should be carried out to evaluate whether radical compartment-based operations according to Höckel, e.g. partial mesometrial resection (PMMR) and therapeutic lymphadenectomy, are suitable for reducing local regional recurrences and also endometrial cancer. If this holds true radiation could be completely removed from the primary therapy and would then be available as a highly effective local and regional method for salvage therapy of recurrence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Wright JD, Barrena Medel NI, Sehouli J et al (2012) Contemporary management of endometrial cancer. Lancet 379:1352–1360

    Article  PubMed  Google Scholar 

  2. Kong A, Jahnson N, Kitchener HC, Lawrie TA (2012) Adjuvant radiotherapy for stage I endometrial cancer: an updated Cochrane systematic review and meta-analysis. J Natl Cancer Inst 21:1625–1634

    Article  Google Scholar 

  3. Scheithauer HR, Schulz DS, Belka C (2011) Endometrial cancer – reduce to the minimum. A new paradigm for adjuvant treatments? Rad Oncol 6:164–169

    Article  Google Scholar 

  4. Johnson N, Bryant A, Miles T et al (201) Adjuvant chemotherapy for endometrial cancer after hysterectomy (review). Cochrane Database Syst Rev (10):CD003175. doi:10.1002/14651858.CD003175.pub2

    Google Scholar 

  5. Horn LC, Meinel A, Handzel R, Einenkel J (2007) Histopathology of endometrial hyperplasia and endometrial carcinoma: an update. Ann Diagn Pathol 11:297–311

    Article  PubMed  Google Scholar 

  6. Dowdy SC, Borah BJ, Bakkum-Gamez JN et al (2012) Prospective assessment of survival, morbidity, and cost associated with lymphadenectomy in low-risk endometrial cancer. Gynecol Oncol 127:5–10

    Article  PubMed  CAS  Google Scholar 

  7. Werner HM, Trovik J, Marcickiewicz J et al (2013) A discordant histological risk classification in preoperative and operative biopsy in endometrial cancer is reflected in metastatic risk and prognosis. Eur J Cancer 49:625–632

    Article  PubMed  CAS  Google Scholar 

  8. Salvesen HB, Haldorsen IS, Trovik J (2012) Markers for individualized therapy in endometrial carcinoma. Lancet Oncol 13:e353–e361

    Article  PubMed  Google Scholar 

  9. Arora V, Quinn MA (2012) Endometrial cancer. Best Pract Res Clin Obstet Gynaecol 26:311–324

    Article  PubMed  Google Scholar 

  10. Hauspy J, Jiménez W, Rosen B et al (2010) Laparscopic surgery for endometrial cancer: a review. J Obstet Gynaecol Can 32:570–579

    PubMed  Google Scholar 

  11. Acholonu UC Jr, Chang-Jackson SC, Radjabi AR, Nezhat FR (2012) Laparoscopy for the management of early-stage endometrial cancer: from experimental to standard of care. J Minim Invasive Gynecol 19:434–442

    Article  PubMed  Google Scholar 

  12. Watari H, Mitamura T, Moriwaki M et al (2009) Survival and failure pattern of patients with endometrial cancer after extensive surgery including systematic pelvic and para-aortic lymphadenectomy followed by adjuvant chemotherapy. Int J Gynecol Cancer 19:1585–1590

    Article  PubMed  Google Scholar 

  13. Gadducci A, Cosio S, Fabrini MG et al (2011) Patterns of failures in endometrial cancer: clinicopathological variables predictive of the risk of local, distant and retroperitoneal failure. Anticancer Res 31:3483–3488

    PubMed  Google Scholar 

  14. Todo Y, Kato H, Minobe S et al (2011) Initial failure site according to primary treatment with or without para-aortic lymphadenectomy in endometrial cancer. Gynecol Oncol 121:314–318

    Article  PubMed  Google Scholar 

  15. Simpkins F, Papdia A, Kunos C et al (2013) Patterns of recurrence in stage I endometrioid endometrial adenocarcinoma with lymphvascular space invasion. Int J Gynecol Cancer 23:98–104

    Article  PubMed  Google Scholar 

  16. Chen SS, Spiegel G (1991) Stage I endometrial carcinoma. Role of omental biopsy and omentectomy. J Reprod Med 36(9):627–629

    PubMed  CAS  Google Scholar 

  17. Saygili U, Kavaz S, Altunyurt S et al (2001) Omentectomy, peritoneal biopsy and appendectomy in patients with clinical stage I endometrial carcinoma. Int J Gynecol Cancer 11(6):471–474

    Article  PubMed  CAS  Google Scholar 

  18. Gehrig PA, Van Le L, Fowler WC Jr (2003) The role of omentectomy during the surgical staging of uterine serous carcinoma. Int J Gynecol Cancer 13(2):212–215

    Article  PubMed  CAS  Google Scholar 

  19. Giuntoli RL 2nd, Gerardi MA, Yemelyanova AV et al (2012) Stage I noninvasive and minimally invasive uterine serous carcinoma: comprehensive staging associated with improved survival. Int J Gynecol Cancer 22(2):273–279. doi: 10.1097/IGC.0b013e318238df4d

    Article  PubMed  Google Scholar 

  20. Sood BM, Jones J, Gupta S et al (2003) Patterns of failure after the multimodality treatment of uterine papillary serous carcinoma.Int J Radiat Oncol Biol Phys 57(1):208–216

    Article  PubMed  Google Scholar 

  21. Dahmann C, Oates AC, Brand M (2011) Boundary formation and maintenance in tissue development. Nat Rev 12:43–55

    CAS  Google Scholar 

  22. Höckel M (2012) Cancer permeates locally within ontogenetic compartments: clinical evidence and implications for cancer surgery. Future Oncol 8(1):29–36

    Article  PubMed  Google Scholar 

  23. Heald RJ, Rayan DRH (1986) Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 327:1479–1482

    Article  Google Scholar 

  24. Höckel M, Horn LC, Fritsch H (2005) Association between the mesenchymal compartment of uterovaginal organogenesis and local tumour spread in state 1B–2B cervical carcinoma: a prospective study. Lancet Oncol 6:751–756

    Article  PubMed  Google Scholar 

  25. Höckel M, Horn LC, Tetsch E, Einenkel J (2012) Pattern analysis of regional spread and therapeutic lymph node dissection in cervical cancer based on ontogenetic anatomy. Gynecol Oncol 125(1):168–174

    Article  PubMed  Google Scholar 

  26. Kimmig R, Iannaccone A, Buderath P et al (2013) Definition of compartment based radical surgery in uterine cancer—part I: Therapeutic pelvic and periaortic lymphadenectomy by Michael Höckel translated to robotic surgery. ISRN Obstetrics and Gynecology, srticle ID 297921, doi:10.1155/2013/297921

  27. Keys HM, Roberts JA, Brunetto VL et al (2004) A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. 92:744–751

  28. Nout RA, Smit VT, Putter H et al (2010) Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial. Lancet 375(9717):816–823. doi: 10.1016/S0140-6736(09)62163-2

    Article  PubMed  CAS  Google Scholar 

  29. Marnitz S, Köhler C (2012) Current therapy of patients with endometrial carcinoma. Strahlenther Onkol 188:12–20

    Article  PubMed  CAS  Google Scholar 

  30. Creutzberg CL, Nout RA (2011) The role of radiotherapy in endometrial cancer: current evidence and trends. Curr Oncol Rep 13(6):472–478

    Article  PubMed  CAS  Google Scholar 

  31. Huh WK, Straughn JM Jr, Mariani A et al (2007) Salvage of isolated vaginal recurrences in women with surgical stage I endometrial cancer: a multi-institutional experience. Int J Gynecol Cancer 17(4):886–889

    Article  PubMed  CAS  Google Scholar 

  32. Vale CL, Tierney J, Bull SJ, Symonds PR (2012) Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma. Cochrane Database Syst Rev 8:CD003915. doi: 10.1002/14651858.CD003915.pub4

    PubMed  Google Scholar 

  33. Hogberg T (2011) What is the role of chemotherapy in endometrial cancer? Curr Oncol Rep 13:413–441

    Article  Google Scholar 

  34. Neubauer NL, Lurain JR (2011) The role of lymphadenectomy in surgical staging of endometrial cancer. Int J Surg Oncol ID 814649, 7pg

  35. Shah PH, Kudrimoti M, Feddock J, Randall M (2011) Adjuvant treatment for stage IIIC endometrial cancer: options and controversies. Gynecol Oncol 122(3):675–683. doi: 10.1016/j.ygyno.2011.05.018 (Epub 12 Jun 2011)

    Article  PubMed  CAS  Google Scholar 

  36. Westin SN, Broaddus RR (2012) Personalized therapy in endometrial cancer: challenges and opportunities. Cancer Biol Ther 13:1–13

    Article  PubMed  CAS  Google Scholar 

  37. AlHilli MM, Podratz KC, Dowdy SC et al. (2013) Preoperative biopsy and intraoperative tumor diameter predict lymph node dissemination in endometrial cancer. Gynecol Oncol 128(2):294−249. doi: 10.1016/j.ygyno.2012.10.009. Epub: 2012 Oct 17.

    Article  PubMed  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt für sich und seine Koautoren an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R. Kimmig.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kimmig, R., Aktas, B. & Heubner, M. Endometriumkarzinom – operative Strategie und Adjuvanz. Gynäkologe 46, 339–344 (2013). https://doi.org/10.1007/s00129-013-3185-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00129-013-3185-z

Schlüsselwörter

Keywords

Navigation